Q3 2026
-
Treace Narrows Losses as Procedure Volumes Surge Despite Revenue Dip
Treace Medical narrowed its Q3 2026 net loss to $12.6 million and reduced costs, offsetting a slight revenue dip through surging surgical procedure volumes.
-
Nvidia Posts Record $57 Billion Revenue in Q3 2026, Driven by AI Demand and Data Center Growth
Nvidia’s Q3 2026 earnings report reveals an unprecedented $57 billion in revenue, propelled by soaring demand for AI infrastructure and data center solutions. The company’s strategic partnerships and next-gen product launches mark a transformative moment in the tech industry.